Business
Opthea Doses First Patient in Ph2a Trial for OPT-302 in DME
Opthea Doses First Patient in Ph2a Trial for OPT-302 in DME
About this update from Opthea Limited
[{"type":"text","content":"Opthea Ltd has released a press release. View Attachment","length":224,"tagName":"div"}]